Prophylactic therapy with recombinant ADAMTS13 safe for congenital TTP
1. In this randomized controlled trial, among individuals with congenital thrombotic thrombocytopenic purpura (TTP), no patients in a prophylactic group ...
1. In this randomized controlled trial, among individuals with congenital thrombotic thrombocytopenic purpura (TTP), no patients in a prophylactic group ...
Click here to read this study in NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be ...
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.